Methylation regulates HEY1 expression in glioblastoma

Oncotarget

Volumn 8, Issue 27, 2017, Pages 44398-44409

  Tsung, Andrew J ^a,b   Guda, Maheedhara R ^a   Asuthkar, Swapna ^a   Labak, Collin M ^a   Purvis, Ian J ^a   Lu, Yining ^a   Jain, Neha ^a   Bach, Sarah E ^c   Prasad, Durbaka V R ^d   Velpula, Kiran K ^a,d  

^a UNIVERSITY OF ILLINOIS   (United States)

^b Illinois Neurological Institute   (United States)

^c Department of Pathology ^*  (United States)

^d YOGI VEMANA UNIVERSITY   (India)

Author keywords

DNMT1; Glioblastoma; Methylation; P53; Proliferation

Indexed keywords

BUTYRIC ACID; DNA METHYLTRANSFERASE 1; MEMBRANE PROTEIN; NOTCH RECEPTOR; PROTEIN HEY1; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CELL CYCLE PROTEIN; HEY1 PROTEIN, HUMAN; PROTEIN BINDING; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; DATA MINING; DISEASE ASSOCIATION; DNA METHYLATION; FLOW CYTOMETRY; GENE SILENCING; GLIOBLASTOMA; GLIOMA CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PHENOTYPE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR INVASION; TUMOR SUPPRESSOR GENE; BIOLOGICAL MODEL; BRAIN TUMOR; CELL CYCLE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN NEOPLASMS; BUTYRIC ACID; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GLIOBLASTOMA; HUMANS; MODELS, BIOLOGICAL; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTION FACTORS;

EID: 85021842738     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.17897     Document Type: Article

References (30)

1. Darefsky AS, King JT Jr, Dubrow R. Adult glioblastoma multiforme survival in the temozolomide era: a populationbased analysis of Surveillance, Epidemiology, and End Results registries. Cancer. 2012; 118:2163-2172.
2. Huang Z, Cheng L, Guryanova OA, Wu Q, Bao S. Cancer stem cells in glioblastoma molecular signaling and therapeutic targeting. Protein & cell. 2010; 1:638-655.
3. Eskilsson E, Rosland GV, Talasila KM, Knappskog S, Keunen O, Sottoriva A, Foerster S, Solecki G, Taxt T, Jirik R, Fritah S, Harter PN, Valk K, et al. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. Neuro-oncology. 2016; 18:1644-1655.
4. Phillips E, Lang V, Bohlen J, Bethke F, Puccio L, Tichy D, Herold-Mende C, Hielscher T, Lichter P, Goidts V. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism. International journal of cancer. 2016; 139:1776-1787.
5. Irshad K, Mohapatra SK, Srivastava C, Garg H, Mishra S, Dikshit B, Sarkar C, Gupta D, Chandra PS, Chattopadhyay P, Sinha S, Chosdol K. A combined gene signature of hypoxia and notch pathway in human glioblastoma and its prognostic relevance. PloS one. 2015; 10:e0118201.
6. Guichet PO, Guelfi S, Teigell M, Hoppe L, Bakalara N, Bauchet L, Duffau H, Lamszus K, Rothhut B, Hugnot JP. Notch1 stimulation induces a vascularization switch with pericyte-like cell differentiation of glioblastoma stem cells. Stem cells (Dayton, Ohio). 2015; 33:21-34.
7. Woltje K, Jabs M, Fischer A. Serum induces transcription of Hey1 and Hey2 genes by Alk1 but not Notch signaling in endothelial cells. PloS one. 2015; 10: e0120547.
8. Henderson AM, Wang SJ, Taylor AC, Aitkenhead M, Hughes CC. The basic helix-loop-helix transcription factor HESR1 regulates endothelial cell tube formation. The Journal of biological chemistry. 2001; 276:6169-6176.
9. Kushwaha G, Dozmorov M, Wren JD, Qiu J, Shi H, Xu D. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia. Human genomics. 2016; 10:18-016-0071-5.
10. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002; 21:5427-5440.
11. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes & development. 2011; 25:1010-1022.
12. de Haan JB, Gevers W, Parker MI. Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts. Cancer research. 1986; 46:713-716.
13. Sarkar S, Abujamra AL, Loew JE, Forman LW, Perrine SP, Faller DV. Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling. Anticancer Research. 2011; 31:2723-2732.
14. Ludwig AK, Zhang P, Cardoso MC. Modifiers and Readers of DNA Modifications and Their Impact on Genome Structure, Expression, and Stability in Disease. Frontiers in genetics. 2016; 7:115.
15. Kumar P, Naumann U, Aigner L, Wischhusen J, Beier CP, Beier D. Impaired TGF-beta induced growth inhibition contributes to the increased proliferation rate of neural stem cells harboring mutant p53. American journal of cancer research. 2015; 5:3436-3445.
16. Lee SW, Kim HK, Lee NH, Yi HY, Kim HS, Hong SH, Hong YK, Joe YA. The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells. Cancer letters. 2015; 360:195-204.
17. Dando I, Cordani M, Donadelli M. Mutant p53 and mTOR/PKM2 regulation in cancer cells. IUBMB life. 2016; 68:722-726.
18. Gaetani P, Hulleman E, Levi D, Quarto M, Scorsetti M, Helins K, Simonelli M, Colombo P, Baena y Rodriguez R. Expression of the transcription factor HEY1 in glioblastoma: a preliminary clinical study. Tumori. 2010; 96:97-102.
19. Hulleman E, Quarto M, Vernell R, Masserdotti G, Colli E, Kros JM, Levi D, Gaetani P, Tunici P, Finocchiaro G, Baena RR, Capra M, Helin K. A role for the transcription factor HEY1 in glioblastoma. Journal of Cellular and Molecular Medicine. 2009; 13:136-146.
20. Tucker KL. Methylated cytosine and the brain: a new base for neuroscience. Neuron. 2001; 30:649-652.
21. Kim EH, Kim HS, Kim SU, Noh EJ, Lee JS, Choi KS. Sodium butyrate sensitizes human glioma cells to TRAILmediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP. Oncogene. 2005; 24:6877-6889.
22. Linz U. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study:5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466). Cancer. 2010; 116:1844-1846.
23. Belandia B, Powell SM, Garcia-Pedrero JM, Walker MM, Bevan CL, Parker MG. Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Molecular and cellular biology. 2005; 25:1425-1436.
24. Xie C, Wu B, Chen B, Shi Q, Guo J, Fan Z, Huang Y. Histone deacetylase inhibitor sodium butyrate suppresses proliferation and promotes apoptosis in osteosarcoma cells by regulation of the MDM2-p53 signaling. OncoTargets and therapy. 2016; 9:4005-4013.
25. Yen RW, Vertino PM, Nelkin BD, Yu JJ, el-Deiry W, Cumaraswamy A, Lennon GG, Trask BJ, Celano P, Baylin SB. Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic acids research. 1992; 20:2287-2291.
26. Thota B, Arimappamagan A, Kandavel T, Shastry AH, Pandey P, Chandramouli BA, Hegde AS, Kondaiah P, Santosh V. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma. Journal of neurosurgery. 2014; 121:374-383.
27. Steinbach JP, Kozmik Z, Pfeffer P, Aguzzi A. Overexpression of Pax5 is not sufficient for neoplastic transformation of mouse neuroectoderm. International journal of cancer. 2001; 93:459-467.
28. Rao JS, Bhoopathi P, Chetty C, Gujrati M, Lakka SS. MMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16(INK4a) and mitogen-activated protein kinase pathway. Cancer research. 2007; 67:4956-4964.
29. Lakka SS, Gondi CS, Dinh DH, Olivero WC, Gujrati M, Rao VH, Sioka C, Rao JS. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by doublestranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas. The Journal of biological chemistry. 2005; 280:21882-21892.
30. Mukhopadhyay NK, Ferdinand AS, Mukhopadhyay L, Cinar B, Lutchman M, Richie JP, Freeman MR, Liu BC. Unraveling androgen receptor interactomes by an arraybased method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor. Experimental cell research. 2006; 312:3782-3795.